MedTrace Logo

Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects

NCT04667442 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 137

Last updated 2021-12-27

No results posted yet for this study

Summary

Prospective samples will be collected to evaluate the agreement between a EUA RT-PCR test as the comparator method against the Nanomix eLab® system.

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

Nanomix eLab® COVID-19 Rapid Antigen Panel (non-interventional)

COVID-19 Rapid Antigen Diagnostic Test

Sponsors & Collaborators

  • Nanomix

    lead INDUSTRY

Principal Investigators

  • Tina Landess · Nanomix

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2021-12-14
Completion
2021-12-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04667442 on ClinicalTrials.gov